Artivion, Inc. announced on April 23 that it will release its financial results for the first quarter of 2026 on Thursday, May 7, after the market closes. The company said a teleconference call and live webcast to discuss the results will be held at 4:30 p.m. Eastern Time on the same day.
The upcoming financial announcement is significant as it provides investors and stakeholders with insight into Artivion’s recent performance in the cardiac and vascular surgery sector. Pat Mackin, Chairman, President and Chief Executive Officer of Artivion, will host a question-and-answer session following the discussion of results.
To access the live teleconference, listeners are instructed to dial 201-689-8261 shortly before the scheduled time. A replay will be available about one hour after completion by calling either (toll free) 877-660-6853 or 201-612-7415 using conference number 13759187. The live webcast and replay can also be accessed through the Investors section of Artivion’s website at www.artivion.com under Webcasts & Presentations. The earnings press release containing detailed financial information for both the completed quarter and full year will also be available online.
Artivion is headquartered in suburban Atlanta, Georgia, focusing on developing solutions for complex aortic diseases faced by cardiac and vascular surgeons. Its main product groups include aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. The company markets its products in over 100 countries worldwide.
PR Newswire operates in more than 170 countries with support in over 40 languages according to its official website (official website). It aims to deliver global reach for press release distribution through an extensive network of newsrooms and influencers (official website). PR Newswire features expert editors who provide around-the-clock support as well as SEO guidance (official website). The service collaborates with more than half a million media outlets globally (official website) while offering AI-enhanced content tools alongside social sharing features (official website).
The upcoming disclosure from Artivion may influence industry observers’ expectations regarding trends in medical device innovation focused on cardiovascular health.
